BioSpace News Archive

ApiFix Ltd., a leading motion-preservation scoliosis correction company, today announced completion of its Series B equity financing

AMPEL BioSolutions, a precision medicine technology company and MedNet Solutions, an eClinical technology company, today announced they will host and sponsor a Virginia Biotechnology Association (Virginia Bio) educational and networking event.

Global diabetes nonprofit Beyond Type 1 has been awarded the People’s Voice Award for Best Writing in the 23rd Annual Webby Awards for the project Previously Healthy.

Intersect ENT, Inc. announced that it will release first quarter financial results on May 6, 2019.

SLATE Phase 1 clinical study may be accelerated by up to six months from the company’s prior expectations by leveraging pre-clinical data generated for the original GRANITE Investigational New Drug (IND) application.

To continue serving its clientele base, a focus on SCM was needed.

Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, will participate in the Bank of America Merrill Lynch Healthcare Conference at the Encore Hotel in Las Vegas, Nevada.

Several new institutional investors participated alongside current investors, including Malin who invested $4 million as part of the financing transaction.

Related products including Clopidol, Decoquinate, Diclazuril, Dinitolmide, Lasalocid, Maduramicin, Mebendazole, and so on are all available at Creative Diagnostics.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets, and advanced analytics, announce today that it has appointed Dr. Bahija Jallal, PhD, to its Board of Directors, effective April 17, 2019.